The Drug Risk Resource Center is the Web's largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com.
New York, NY (PRWEB) January 01, 2013
The prescription drug resource center DrugRisk.com is announcing the most-searched topics in its comprehensive database of medication and medical device information for 2012. Among these is the popular birth control device NuvaRing.
“DrugRisk's goal is to improve patient safety by sharing the latest drug warnings, recalls, studies and litigation news. Unfortunately we've seen an increasing amount of searches for NuvaRing side effects or NuvaRing lawsuits, which may indicate more women have been affected or want to know their legal options,” explains DrugRisk representative Ryan Mayer.
The resource center previously reported that as many as 1,028 patients have filed a NuvaRing lawsuit claiming blood clots in a special federal court in Missouri.* The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri. U.S. District Judge Rodney Sippel, who presides over the cases, recently delayed the start of trials to July 8, 2013.**
Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Experts have related vaginal rings like NuvaRing to higher blood clot risks than with traditional birth control pills.
The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
Due to the specialized nature of federal MDL drug injury cases, the DrugRisk Center only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
For more information on the research, side effects, a possible NuvaRing class action lawsuit and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
**Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebnuvaring-class/action-lawsuit/prweb10282901.htm
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.